How to Register as a Monoclonal Antibody Infusion Center

The federal government is committed to ensuring health equity and that all newly diagnosed COVID patients who qualify have fair access to FREE Monoclonal Antibody therapies. The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR) is overseeing the distribution of these national supplies. (How much of the antibody supply states and territories receive each week is based on their percentage of the country's total number of confirmed COVID-19 patients and the total number of confirmed COVID-19 patients hospitalized during the previous 7 days.)

Health care institutions with the capability to distribute infusions can order the Monoclonal Antibody therapies directly from sole distributor: AmerisourceBergen (ABC). There is no supply shortage of these drugs, and the federal government is meeting the needs of interested treatment facilities. These therapies are FREE to requesting sites.

REGEN-COV has been approved for subcutaneous injection as well as infusion in all states. As of May 26, ASPR has stopped distribution of Eli Lilly’s product bamlanivimab/etesevimab to the following states until further notice: AZ, CA, FL, IL, IN, MA, OR, & WA due to potential variant resistance.

Guide: Ordering Process Guidelines (ABC)

Order: Direct Order Form (ABC)

Register: For facilities and health care providers interested in launching infusion programs for high-risk patients with COVID-19, Survivor Corps has FREE Physician Resources available to help you set up your internal and external communications and outreach strategies. FAQs are available in English & Spanish as well as a free library of GIFs highlighting mAbs treatment for use on social media.

ASPR has many resources available, including a digital toolkit your facility can use to educate providers and patients on social media. HHS has launched a CombatCovid.HHS.gov website in English & Spanish as a mAbs resource for providers and patients.